James Testa

414 total citations
15 papers, 291 citations indexed

About

James Testa is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, James Testa has authored 15 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in James Testa's work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Cell Function and Interaction (4 papers). James Testa is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Cell Function and Interaction (4 papers). James Testa collaborates with scholars based in United States and Belgium. James Testa's co-authors include Ramila Philip, Joseph D. Comber, Vivekananda Shetty, Laurence C. Eisenlohr, Gomathinayagam Sinnathamby, Julie Hafner, Laura Vitale, Li-Zhen He, Jenifer Widger and Lawrence J. Thomas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

James Testa

15 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Testa United States	9	145	131	75	62	51	15	291
Maria-Dorothea Nastke United States	9	215 1.5×	196 1.5×	86 1.1×	56 0.9×	25 0.5×	12	374
Ganit Yarden Israel	6	114 0.8×	278 2.1×	189 2.5×	47 0.8×	49 1.0×	7	440
Susan E. Vleck United States	6	96 0.7×	212 1.6×	131 1.7×	151 2.4×	50 1.0×	9	434
Dora Pinto Italy	10	93 0.6×	264 2.0×	57 0.8×	50 0.8×	52 1.0×	11	380
Susan Strobl United States	11	89 0.6×	294 2.2×	132 1.8×	48 0.8×	27 0.5×	13	384
Ashraf S. Yousif United States	9	157 1.1×	146 1.1×	39 0.5×	67 1.1×	58 1.1×	21	351
Leontios Pappas United States	6	161 1.1×	160 1.2×	29 0.4×	151 2.4×	55 1.1×	7	401
Gustáv Russ Slovakia	11	159 1.1×	338 2.6×	68 0.9×	150 2.4×	32 0.6×	15	480
Raul Louzao United States	7	89 0.6×	128 1.0×	39 0.5×	59 1.0×	41 0.8×	10	273
Mohammed Dhalla Saudi Arabia	7	144 1.0×	141 1.1×	54 0.7×	106 1.7×	28 0.5×	10	388

Countries citing papers authored by James Testa

Since Specialization

Citations

This map shows the geographic impact of James Testa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Testa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Testa more than expected).

Fields of papers citing papers by James Testa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Testa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Testa. The network helps show where James Testa may publish in the future.

Co-authorship network of co-authors of James Testa

This figure shows the co-authorship network connecting the top 25 collaborators of James Testa. A scholar is included among the top collaborators of James Testa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Testa. James Testa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Pillarisetti, Kodandaram, Danlin Yang, Leopoldo Luistro, et al.. (2025). Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models. Blood. 147(8). 834–847. 3 indexed citations

Yang, Danlin, Jianhong Yao, Melissa Smith, et al.. (2023). Characterization of JNJ-79635322, a Novel BCMAxGPRC5DxCD3 T-Cell Redirecting Trispecific Antibody, for the Treatment of Multiple Myeloma. Blood. 142(Supplement 1). 456–456. 19 indexed citations

Thomas, Lawrence J., Li-Zhen He, James Testa, et al.. (2018). Abstract 3816: Efficacy of CDX-1140, an agonist CD40 antibody, in preclinical tumor models. Cancer Research. 78(13_Supplement). 3816–3816. 1 indexed citations

Wasiuk, Anna, James Testa, Laura Vitale, et al.. (2017). CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy. The Journal of Immunology. 199(12). 4110–4123. 40 indexed citations

He, Li-Zhen, James Testa, Anna Wasiuk, et al.. (2016). CDX-1140, a Novel Agonist CD40 Antibody with Potent Anti-Lymphoma Activity. Blood. 128(22). 1848–1848. 6 indexed citations

He, Li-Zhen, Anna Wasiuk, James Testa, et al.. (2015). The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P188–P188. 2 indexed citations

Comber, Joseph D., et al.. (2014). MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic Infection. SHILAP Revista de lepidopterología. 2014. 1–11. 19 indexed citations

He, Li-Zhen, Lawrence J. Thomas, James Testa, et al.. (2013). Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models. Journal for ImmunoTherapy of Cancer. 1(Suppl 1). P76–P76. 3 indexed citations

Testa, James, et al.. (2012). MHC Class I-Presented T Cell Epitopes Identified by Immunoproteomics Analysis Are Targets for a Cross Reactive Influenza-Specific T Cell Response. PLoS ONE. 7(11). e48484–e48484. 29 indexed citations

10.

Shetty, Vivekananda, et al.. (2012). Quantitative immunoproteomics analysis reveals novel MHC class I presented peptides in cisplatin-resistant ovarian cancer cells. Journal of Proteomics. 75(11). 3270–3290. 23 indexed citations

11.

Testa, James, Vivekananda Shetty, Gomathinayagam Sinnathamby, et al.. (2012). Conserved MHC Class I–Presented Dengue Virus Epitopes Identified by Immunoproteomics Analysis Are Targets for Cross-Serotype Reactive T-Cell Response. The Journal of Infectious Diseases. 205(4). 647–655. 33 indexed citations

12.

Testa, James & Ramila Philip. (2012). Role of T-cell Epitope-Based Vaccine in Prophylactic and Therapeutic Applications. Future Virology. 7(11). 1077–1088. 47 indexed citations

13.

Liu, Yuanjie, James Testa, Ramila Philip, Timothy M. Block, & Anand S. Mehta. (2011). A Ubiquitin Independent Degradation Pathway Utilized by a Hepatitis B Virus Envelope Protein to Limit Antigen Presentation. PLoS ONE. 6(9). e24477–e24477. 11 indexed citations

14.

Testa, James, et al.. (2010). Exosome-Driven Antigen Transfer for MHC Class II Presentation Facilitated by the Receptor Binding Activity of Influenza Hemagglutinin. The Journal of Immunology. 185(11). 6608–6616. 51 indexed citations

15.

DeGeorge, Katharine C, Brent R. DeGeorge, James Testa, & Jay L. Rothstein. (2008). Inhibition of oncogene-induced inflammatory chemokines using a farnesyltransferase inhibitor. Journal of Inflammation. 5(1). 3–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact